Clinical trials
Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,294 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 63 |
| 2001 | 36 |
| 2002 | 55 |
| 2003 | 52 |
| 2004 | 58 |
| 2005 | 58 |
| 2006 | 63 |
| 2007 | 61 |
| 2008 | 51 |
| 2009 | 51 |
| 2010 | 59 |
| 2011 | 50 |
| 2012 | 47 |
| 2013 | 38 |
| 2014 | 35 |
| 2015 | 31 |
| 2016 | 30 |
| 2017 | 35 |
| 2018 | 30 |
| 2019 | 39 |
| 2020 | 42 |
| 2021 | 41 |
| 2022 | 35 |
| 2023 | 34 |
| 2024 | 13 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,294 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 114 |
| Fred Hutchinson Cancer Center | 71 |
| Children's Oncology Group | 60 |
| M.D. Anderson Cancer Center | 44 |
| St. Jude Children's Research Hospital | 36 |
| Memorial Sloan Kettering Cancer Center | 32 |
| Case Comprehensive Cancer Center | 24 |
| Novartis Pharmaceuticals | 21 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 20 |
| City of Hope Medical Center | 17 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1,294 |
| Leukemia, Myeloid, Acute | 490 |
| Lymphoma, Non-Hodgkin | 432 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 418 |
| Leukemia | 404 |
| Burkitt Lymphoma | 378 |
| Lymphoma, Large B-Cell, Diffuse | 344 |
| Lymphoma, Follicular | 337 |
| Lymphoma, Mantle-Cell | 337 |
| Hodgkin Disease | 325 |
Trials
Showing 1 to 25 of 1,294. Each trial links to its page on Pharma Observatory.
1,194 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.